Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
321
-
Total 13F shares, excl. options
-
123M
-
Shares change
-
+471K
-
Total reported value, excl. options
-
$3.75B
-
Value change
-
+$12.5M
-
Put/Call ratio
-
1.72
-
Number of buys
-
141
-
Number of sells
-
-148
-
Price
-
$30.43
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q4 2021
377 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q4 2021.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 321 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 123M shares
of 159M outstanding shares and own 77.72% of the company stock.
Largest 10 shareholders include FMR LLC (21.2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (12.5M shares), VANGUARD GROUP INC (12M shares), Bellevue Group AG (10.4M shares), BlackRock Inc. (8.54M shares), ARK Investment Management LLC (7.08M shares), Clearbridge Investments, LLC (5.88M shares), STATE STREET CORP (3.91M shares), GEODE CAPITAL MANAGEMENT, LLC (1.83M shares), and FIRST TRUST ADVISORS LP (1.68M shares).
This table shows the top 321 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.